|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | AMBMP | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C19H18N4O3·HCl |
||||||||||
| 分子量 | 386.83 | CAS No. | 2095432-75-8 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 77 mg/mL (199.05 mM) | ||||||||
| Water | Insoluble | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | BML-284 (Wnt agonist 1) is a cell permeable Wnt signaling pathway activator, which induces β-catenin- and TCF-dependent transcriptional activity with EC50 of 0.7 μM. |
|---|---|
| in vitro | BML-284 (Wnt agonist 1) does not inhibit the activity of GSK-3β, and may be a useful tool in the study of physiological processes that involve the Wnt pathway[1]. Exposure of human brain endothelial hCMEC/D3 cells to this compound led to an increase in the percentage of cells exhibiting nuclear or perinuclear β-catenin staining after exposure for 16 h to 10 μM (43 ± 2%, p < 0.01, n = 5) and 20 μM (48 ± 5%, p < 0.01, n = 5) compared with that of control (12 ± 1%, n = 5)[2]. |
| in vivo | BML-284 (Wnt agonist 1) mimics the effects of Wnt at the whole-organism level in a Xenopus model (10 μM), and affects Xenopus embryonic head specification[1]. In animal model (Rat renal IR model), this compound significantly lowered serum levels of creatinine, AST, and LDH, inhibited the production of IL-6 and IL-1β, and MPO activities. It reduced iNOS, nitrotyrosine proteins and 4-hydroxynonenal in the kidneys, improves renal regeneration and function while attenuating inflammation and oxidative stress in the kidneys after IR[3]. |
| 細胞アッセイ | 細胞株 | 293T cells |
|---|---|---|
| 濃度 | 10 μM | |
| 反応時間 | 24 h | |
| 実験の流れ | For high-throughput screening with BML-284 (Wnt agonist 1), 293T cells are transiently transfected with the reporter construct in T75 cell culture flasks. After overnight culture, cells are harvested and replated onto 384-well plates with 1.5×103 cells in each well; 24 h later, this compound solution (1 mM, 500 nL) is added to each well. After incubation for another 24 h, luciferase activity is measured with BrightGlo. |
|
| 動物実験 | 動物モデル | Male adult Sprague-Dawley rats |
| 投薬量 | 5 mg/kg BW | |
| 投与方法 | i.v. |
|

Data from [Data independently produced by , , Int J Oncol, 2017, 51(4):1077-1088]
| NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia [ EMBO Mol Med, 2025, 17(7):1794-1824] | PubMed: 40494896 |
| Stress induces behavioral disorders by promoting microglial phagocytosis via decreasing neuronal Dkk3 [ Mol Psychiatry, 2025, 30(12):5731-5748] | PubMed: 41136744 |
| Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt/β‑catenin signaling pathway [ Oncol Rep, 2025, 53(1)7] | PubMed: 39513580 |
| MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance [ Adv Sci (Weinh), 2024, 11(35):e2308417] | PubMed: 39041891 |
| Colchicine Blocks Abdominal Aortic Aneurysm Development by Maintaining Vascular Smooth Muscle Cell Homeostasis [ Int J Biol Sci, 2024, 20(6):2092-2110] | PubMed: 38617538 |
| β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of the femoral head [ Elife, 2024, 12RP92469] | PubMed: 38376133 |
| IL-33 regulates adipogenesis via Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes [ J Transl Med, 2024, 22(1):363] | PubMed: 38632591 |
| Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine [ Sci Rep, 2024, 14(1):26132] | PubMed: 39477958 |
| Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases [ Cell Rep Med, 2023, 4(1):100881] | PubMed: 36603578 |
| Restoring Wnt signaling in a hormone-simulated postpartum depression model remediated imbalanced neurotransmission and depressive-like behaviors [ Mol Med, 2023, 29(1):101] | PubMed: 37491227 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。